Research Article

Evaluation of Antibacterial Activity of Essential Oils and Their Combination against Multidrug-Resistant Bacteria Isolated from Skin Ulcer

Table 3

Inhibition zone (mm) of combined essential oils against MDR bacteria isolated from wounds at KMU, 2020.

Essential oils, 50 μl/mlμl/discInhibition zone in diameter (mm), pathogen bacteria isolated from wounds
Gram-positive bacteriaGram-negative bacteria
S. aureusE. faecalisE. coliK. pneumoniaeP. aeruginosa
ATCCMRSAATCCVREATCCESBLATCCMDRATCCESBL

R. abyssinicus and C. pustulatus2029 ± 2.129 ± 1.331 ± 1.331 ± 0.623 ± 2.722 ± 1.733 ± 0.433 ± 0.126 ± 0.726 ± 0.9
1019 ± 0.516 ± .2.120 ± 0.721 ± 1.417 ± 0.418 ± 1.022 ± 2.023 ± 1.918 ± 1.118 ± 1.4
513 ± 0.714 ± .0.510 ± 0.611 ± 0.610 ± 0.39 ± 1.415 ± 0.716 ± 2.411 ± 0.88 ± 0.4

C. pustulatus and D. penninervium2027 ± 1.025 ± 0.533 ± 0.132 ± 1.927 ± 1.428 ± 0.1₫32 ± 0.132 ± 0.728 ± 0.729 ± 0.6
1019 ± 0.917 ± .0.127 ± 1.527 ± 0.119 ± 0.419 ± 1.927 ± 1.326 ± 0.518 ± 2.417 ± 0.4
512 ± 0.311 ± .0.817 ± 0.413 ± 0.89 ± 0.310 ± 0.713 ± 0.514 ± 1.312 ± 0.111 ± 1.5

D. penninervium and R. abyssinicus2032 ± 1.132 ± 1.234 ± 0.431 ± 2.123 ± 1.322 ± 0.429 ± 0.329 ± 0.421 ± 0.319 ± 0.4
1026 ± 2.526 ± 0.325 ± 0.624 ± 0.917 ± 1.716 ± 0.820 ± 0.620 ± 0.413 ± 0.414 ± 0.9
513 ± 2.114 ± .0.816 ± 0.417 ± 0.79 ± 1.78 ± 0.515 ± 0.216 ± 0.78 ± 1.88 ± 1.3

Combination of three (1 : 1 : 1 ratio)2034 ± 0.333 ± .1.537 ± 0.237 ± 1.722 ± 1.122 ± 1.635 ± 1.735 ± 0.226 ± 0.826 ± 0.4
1026 ± 0.126 ± .1.124 ± 0.825 ± 0.915 ± 1.216 ± 0.125 ± 2.025 ± 1.417 ± 0.517 ± 0.2
517 ± 1.216 ± .0.918 ± 0.718 ± 0.89 ± 0.79 ± 0.416 ± 0.317 ± 0.912 ± 0.111 ± 1.9

Positive controlSRSRSRSRSR
Negative controlNINININININININININI

Mean ± SD, whereas C = ciprofloxacin; NI = no inhibition zone; NT = not tested; ATCC = susceptible >21 mm IZ, resistant <16 mm IZ, where and when compared to cefoxitin treated MRSA, while and when compared to modern drug treated E. faecalis; and when compared to K. pneumoniae and when compared to modern drug treated P. aeruginosa, and when compared to modern drug treated E. coli.